Meeder Asset Management Inc Mustang Bio, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$2.33 - $4.6 $1,439 - $2,842	-618 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$2.57 - $4.08 $3,831 - $6,083	-1,491 Reduced 70.7%	618 $3,000
Q3 2019 Oct 17, 2019	BUY	$2.74 - $4.65 $161 - $274	59 Added 2.88%	2,109 $7,000
Q2 2019 Aug 05, 2019	BUY	$2.66 - $6.28 $1,252 - $2,957	471 Added 29.83%	2,050 $8,000
Q1 2019 Apr 16, 2019	SELL	$2.95 - $5.61 $23,647 - $44,969	-8,016 Reduced 83.54%	1,579 $5,000
Q4 2018 Jan 17, 2019	BUY	$2.3 - $5.78 $4,232 - $10,635	1,840 Added 23.73%	9,595 $27,000
Q3 2018 Nov 02, 2018	BUY	$5.71 - $7.58 $38,137 - $50,626	6,679 Added 620.72%	7,755 $0
Q2 2018 Jul 24, 2018	BUY	$6.68 - $11.0 $7,187 - $11,836	1,076 New	1,076 $0

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.